Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Wayne State University
841
mi
from
Detroit, MI
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Wayne State University
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
526
mi
from
Albuquerque, NM
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
526
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
RTI International
1054
mi
from
Durham, NC
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
RTI International
1054
mi
from
Durham, NC
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
1424
mi
from
Providence, RI
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Brown University, Women & Infants Hospital of Rhode Island
1424
mi
from
Providence, RI
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
563
mi
from
Houston, TX
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
563
mi
from
Houston, TX
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Utah
777
mi
from
Salt Lake City, UT
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Utah
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Stanford University
1329
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Yale University
1344
mi
from
New Haven, CT
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Yale University
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
1443
mi
from
Boston, MA
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
University of Rochester
1121
mi
from
Rochester, NY
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
University of Rochester
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Duke University
1052
mi
from
Durham, NC
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Duke University
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
899
mi
from
Cleveland, OH
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
Case Western Reserve University, Rainbow Babies and Children's Hospital
899
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center
345
mi
from
Dallas, TX
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center
345
mi
from
Dallas, TX
Click here to add this to my saved trials
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
Clofarabine in Combination With Cytarabine (Ara-C) and G-CSF Priming Followed by Infusion of Ex Vivo Expanded Cord Blood Progenitors for Patients With AML
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
1410
mi
from
Seattle, WA
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
Clofarabine in Combination With Cytarabine (Ara-C) and G-CSF Priming Followed by Infusion of Ex Vivo Expanded Cord Blood Progenitors for Patients With AML
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Santa Clara Valley Medical Center
1317
mi
from
San Jose, CA
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Santa Clara Valley Medical Center
1317
mi
from
San Jose, CA
Click here to add this to my saved trials
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
1329
mi
from
Stanford, CA
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
The Genetics of Chiari Type I Malformation
The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
The Genetics of Chiari Type I Malformation
The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Combined Spinal/Epidural (CSE) Saline Duration/Spread
Effect of Epidural Saline on Duration and Spread of Subsequent Spinal Analgesia/Anesthesia Using a CSE Technique
Status: Enrolling
Updated:  12/31/1969
Forsyth Medical Center-Sara Lee Center for Women's Health
973
mi
from
Winston-Salem, NC
Combined Spinal/Epidural (CSE) Saline Duration/Spread
Effect of Epidural Saline on Duration and Spread of Subsequent Spinal Analgesia/Anesthesia Using a CSE Technique
Status: Enrolling
Updated: 12/31/1969
Forsyth Medical Center-Sara Lee Center for Women's Health
973
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated:  12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
A Phase I/IB Study fo AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Umbilical Cord Blood (UCB) Allogeneic Stem Cell Transplant for Hematologic Malignancies
Status: Enrolling
Updated:  12/31/1969
University Hospitals Seidman Cancer Center
899
mi
from
Cleveland, OH
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Umbilical Cord Blood (UCB) Allogeneic Stem Cell Transplant for Hematologic Malignancies
Status: Enrolling
Updated: 12/31/1969
University Hospitals Seidman Cancer Center
899
mi
from
Cleveland, OH
Click here to add this to my saved trials
Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography
SNP Panels and Risk Assessment in Women Undergoing Mammography
Status: Enrolling
Updated:  12/31/1969
Abramson Cancer Center of the University of Pennsylvania
1223
mi
from
Philadelphia, PA
Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography
SNP Panels and Risk Assessment in Women Undergoing Mammography
Status: Enrolling
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants
Randomized Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants
Status: Enrolling
Updated:  12/31/1969
Children's Memorial Hermann Hospital, Texas Medical Center
572
mi
from
Houston, TX
Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants
Randomized Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants
Status: Enrolling
Updated: 12/31/1969
Children's Memorial Hermann Hospital, Texas Medical Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Fetal Programming of Obesity
Status: Enrolling
Updated:  12/31/1969
Arkansas Children's Nutrition Center
372
mi
from
Little Rock, AR
Fetal Programming of Obesity
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Nutrition Center
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Wayne State University - Hutzel Hospital
841
mi
from
Detroit, MI
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Wayne State University - Hutzel Hospital
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Columbia University
1290
mi
from
New York, NY
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Columbia University
1290
mi
from
New York, NY
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
1038
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Case Western University
899
mi
from
Cleveland, OH
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Case Western University
899
mi
from
Cleveland, OH
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Ohio State University
810
mi
from
Columbus, OH
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Ohio State University
810
mi
from
Columbus, OH
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh-Magee Womens Hospital
974
mi
from
Pittsburgh, PA
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh-Magee Womens Hospital
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Brown University
1424
mi
from
Providence, RI
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Brown University
1424
mi
from
Providence, RI
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Univ of Texas Galveston
609
mi
from
Galveston, TX
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Univ of Texas Galveston
609
mi
from
Galveston, TX
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
University of Utah Medical Center
777
mi
from
Salt Lake City, UT
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
University of Utah Medical Center
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated:  12/31/1969
The University of Texas, Houston
573
mi
from
Houston, TX
Fetal ST Segment and T Wave Analysis in Labor
A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)
Status: Enrolling
Updated: 12/31/1969
The University of Texas, Houston
573
mi
from
Houston, TX
Click here to add this to my saved trials
A Follow-up of the Early Pregnancy Study Cohort.
A Follow-up of the Early Pregnancy Study Cohort
Status: Enrolling
Updated:  12/31/1969
NIEHS, Research Triangle Park
1052
mi
from
Research Triangle Park, NC
A Follow-up of the Early Pregnancy Study Cohort.
A Follow-up of the Early Pregnancy Study Cohort
Status: Enrolling
Updated: 12/31/1969
NIEHS, Research Triangle Park
1052
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated:  12/31/1969
University of Maryland Greenebaum Cancer Center
1148
mi
from
Baltimore, MD
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated: 12/31/1969
University of Maryland Greenebaum Cancer Center
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated:  12/31/1969
University of Chicago Comprehensive Cancer Center
610
mi
from
Chicago, IL
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated: 12/31/1969
University of Chicago Comprehensive Cancer Center
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Veliparib and Temozolomide in Treating Patients With Acute Leukemia
A Phase I Study of the PARP Inhibitor ABT-888 in Combination With Temozolomide in Acute Leukemias
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Assessing Fertility Potential in Female Cancer Survivors
Assessing Fertility Potential in Female Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Penn Reproductive Research Unit, 3701 Market Street, Suite 810
1223
mi
from
Philadelphia, PA
Assessing Fertility Potential in Female Cancer Survivors
Assessing Fertility Potential in Female Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Penn Reproductive Research Unit, 3701 Market Street, Suite 810
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assessing Fertility Potential in Female Cancer Survivors
Assessing Fertility Potential in Female Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Penn Medicine at Radnor, 250 King of Prussia Road
1212
mi
from
Radnor, PA
Assessing Fertility Potential in Female Cancer Survivors
Assessing Fertility Potential in Female Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Penn Medicine at Radnor, 250 King of Prussia Road
1212
mi
from
Radnor, PA
Click here to add this to my saved trials
Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome
Effects of Physical Activity on Insulin Resistance and Adiposity in Polycystic Ovary Syndrome "Poly"
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
634
mi
from
Baton Rouge, LA
Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome
Effects of Physical Activity on Insulin Resistance and Adiposity in Polycystic Ovary Syndrome "Poly"
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
634
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated:  12/31/1969
Allegheny County Health Department Sexually Transmitted Diseases Clinic
974
mi
from
Pittsburgh, PA
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated: 12/31/1969
Allegheny County Health Department Sexually Transmitted Diseases Clinic
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated:  12/31/1969
Magee-Womens Hospital of UPMC
974
mi
from
Pittsburgh, PA
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated: 12/31/1969
Magee-Womens Hospital of UPMC
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated:  12/31/1969
UPMC Mercy Hospital
972
mi
from
Pittsburgh, PA
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
The Importance of Anti-anaerobic Therapy for Acute PID
Status: Enrolling
Updated: 12/31/1969
UPMC Mercy Hospital
972
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
Phase II Study of the Addition of Azacitidine (NSC#102816) to Reduced-Intensity Conditioning Allogeneic Transplantation for Myelodysplasia (MDS) and Older Patients With AML
Status: Enrolling
Updated:  12/31/1969
Beebe Medical Center
1229
mi
from
Lewes, DE
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
Phase II Study of the Addition of Azacitidine (NSC#102816) to Reduced-Intensity Conditioning Allogeneic Transplantation for Myelodysplasia (MDS) and Older Patients With AML
Status: Enrolling
Updated: 12/31/1969
Beebe Medical Center
1229
mi
from
Lewes, DE
Click here to add this to my saved trials